Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects

NCT00332137 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00332137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00332137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2005
Completion date
August 31, 2007
Enrollment
36
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

health